目录肽产品
SOMA-015A
DOTA-[Tyr3]-Octreotide
DOTA-DPhe-Cys-Phe-DTrp-Lys-Thr-Cys-Thr-ol (Cys2&Cys7 bridge)
DOTA-DPhe-Cys-Phe-DTrp-Lys-Thr-Cys-Thr-ol (Cys2&Cys7 bridge)
Size：0.5
P1(RMB)：1073
MW：1405.7
One letter sequence：DOTA-fCFwKTCT-ol (C2&C7 bridge)
Molecular Formula：C65H92N14O17S2
Description：A group of compounds comprising DOTA, a metal chelator that carries a radionuclide and octreotide (an octapeptide that is a potent somatostatin (SST)) analog (where DOTA is tetra-aza-cyclododecane-N N'N\"N-\"'-tetra-acetate).
Literature Reference：Breeman, W. et al. Int. J. Cancer 104, 376 (2003); Chinol, M. et al. Semin. Nucl. Med. 32,141(2002); De Jong, M. et al. semin Nucl. Med. 32,133(2002).
Cas：
P1(RMB)：1073
MW：1405.7
One letter sequence：DOTA-fCFwKTCT-ol (C2&C7 bridge)
Molecular Formula：C65H92N14O17S2
Description：A group of compounds comprising DOTA, a metal chelator that carries a radionuclide and octreotide (an octapeptide that is a potent somatostatin (SST)) analog (where DOTA is tetra-aza-cyclododecane-N N'N\"N-\"'-tetra-acetate).
Literature Reference：Breeman, W. et al. Int. J. Cancer 104, 376 (2003); Chinol, M. et al. Semin. Nucl. Med. 32,141(2002); De Jong, M. et al. semin Nucl. Med. 32,133(2002).
Cas：
